Chang Gung Memorial Hospital- Linkou

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, myeloid leukemia, neoplasm	Recruiting	Phase 1	2025-07-31		NCT05659732

Clinical trials